Rare diseases remain one of the greatest areas of unmet need in medicine. Despite significant advances in potential treatment modalities, genetics and our understanding of disease biology, the vast majority of rare diseases still have no approved treatment options. The U.S. Food and Drug Administration (FDA) recently noted that only approximately 5% of rare diseases […]